Growth Metrics

Erasca (ERAS) Total Current Liabilities (2020 - 2026)

Erasca posted quarterly Total Current Liabilities of $26.7 million for Q1 2026, up 4.68% year-on-year from $25.5 million in Q1 2025, and down 6.48% on a QoQ basis from $28.5 million in Q4 2025.

Erasca (ERAS) has 7 years of Total Current Liabilities data on file, last reported at $26.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 4.68% year-over-year to $26.7 million; the trailing twelve-month figure through Mar 2026 stood at $26.7 million (up 4.68% YoY), and the FY2025 full-year result was $28.5 million, down 9.19% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $26.7 million, down from $28.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $48.7 million in Q4 2022 and bottomed at $21.4 million in Q1 2022.
  • The 5-year median for Total Current Liabilities is $26.7 million (2023), against an average of $28.0 million.
  • The widest annual swing landed in 2022, when Total Current Liabilities soared 85.68%; it then slumped 46.28% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $48.7 million in 2022, then sank by 46.28% to $26.2 million in 2023, then climbed by 20.03% to $31.4 million in 2024, then decreased by 9.19% to $28.5 million in 2025, then retreated by 6.48% to $26.7 million in 2026.
  • The last three Total Current Liabilities figures came in at $26.7 million (Q1 2026), $28.5 million (Q4 2025), and $28.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Erasca 4.21 Bn 3.97 Bn - 26.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 26.66 Mn
Dec 31, 2025 28.51 Mn
Sep 30, 2025 28.71 Mn
Jun 30, 2025 28.15 Mn
Mar 31, 2025 25.47 Mn
Dec 31, 2024 31.40 Mn
Sep 30, 2024 30.03 Mn
Jun 30, 2024 24.89 Mn
Mar 31, 2024 30.24 Mn
Dec 31, 2023 26.16 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 23.29 Mn
Mar 31, 2023 25.52 Mn
Dec 31, 2022 48.69 Mn
Sep 30, 2022 27.68 Mn
Jun 30, 2022 22.32 Mn
Mar 31, 2022 21.39 Mn
Dec 31, 2021 26.22 Mn
Sep 30, 2021 19.59 Mn
Jun 30, 2021 17.91 Mn
Dec 31, 2020 13.68 Mn